Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer

Documenti analoghi

• Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial
  di: Phillips, Kelly Anne, et al.
  Pubblicazione: (2010)
• Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial
  di: Phillips, Kelly-Anne, et al.
  Pubblicazione: (2010)
• The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause
  di: Chirgwin, Jacquie, et al.
  Pubblicazione: (2011)
• Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
  di: DeCensi, Andrea, et al.
  Pubblicazione: (2014)
• Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial
  di: Ruhstaller, Thomas, et al.
  Pubblicazione: (2019)